Home Featured Page 283

Featured

Latest

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

Pα+ Psychedelic Bulletin #208: Psychedelic CEOs’ FDA Wish-List; APA Division 56 President Talks Psychedelics; Compass’ PTSD Study Published; Cybin Ousts Drysdale

BREAKING: FDA Publishes Lykos Therapeutics’ MDMA Complete Response Letter (CRL)

Psychedelic Researchers Respond to FDA’s Push to Reduce Animal Testing

Massachusetts General Hospital to Study How Psychedelics Influence the Brain

Can LSD cure our pandemic anxiety? MindMed is spending big to...

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Enters...

The Veterans’ Experience: Psychedelic Treatments for PTSD

Red Light Holland Receives Receipt for Final Short-form Prospectus for Previously...

Numinus announces milestones in compassionate access trial for MDMA-assisted therapy in...

MindMed Reaches Agreement to Acquire HealthMode, a Leading Machine Learning Digital...

MINDCURE Announces Official Release of Nootropic and Adaptogen Products, Available on...

Lobe Sciences Successfully Completes Proof-of-Concept of Proprietary Nasal Mist Device

Silo Pharma Licenses Novel Peptide-Guided Drug Delivery Approach for the Treatment...

1...282283284...296 Page 283 of 296

EDITOR PICKS

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

Pα+ Psychedelic Bulletin #208: Psychedelic CEOs’ FDA Wish-List; APA Division 56...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

Pα+ Psychedelic Bulletin #208: Psychedelic CEOs’ FDA Wish-List; APA Division 56 President Talks Psychedelics; Compass’ PTSD Study Published; Cybin Ousts Drysdale

BREAKING: FDA Publishes Lykos Therapeutics’ MDMA Complete Response Letter (CRL)

Psychedelic Researchers Respond to FDA’s Push to Reduce Animal Testing

Massachusetts General Hospital to Study How Psychedelics Influence the Brain

Can LSD cure our pandemic anxiety? MindMed is spending big to...

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Enters...

The Veterans’ Experience: Psychedelic Treatments for PTSD

Red Light Holland Receives Receipt for Final Short-form Prospectus for Previously...

Numinus announces milestones in compassionate access trial for MDMA-assisted therapy in...

MindMed Reaches Agreement to Acquire HealthMode, a Leading Machine Learning Digital...

MINDCURE Announces Official Release of Nootropic and Adaptogen Products, Available on...

Lobe Sciences Successfully Completes Proof-of-Concept of Proprietary Nasal Mist Device

Silo Pharma Licenses Novel Peptide-Guided Drug Delivery Approach for the Treatment...

EDITOR PICKS

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

Pα+ Psychedelic Bulletin #208: Psychedelic CEOs’ FDA Wish-List; APA Division 56...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY